CCL2 and cardiovascular disorder: Recently published studies have stated that higher plasma MCP-1 levels are associated with higher cardiovascular mortality, even in individuals without established cardiovascular disease, which is demonstrative of the role of MCP-1-signaling in atherosclerosis [42].